Search results for "HEART"

showing 10 items of 3201 documents

0137 : Takotsubo cardiomyopathy following acute cerebral events

2016

International audience; ObjectiveTakotsubo cardiomyopathy is characterized by a transient apical ventricular dysfunction typically induced by an acute stress. Acute cerebral events including ischemic stroke (IS) or Epileptic Event (EE) may both be associated with massive catecholamine release. We aimed to identify the characteristics and outcomes of patients who experienced Takotsubo syndrome complicating an IS or EE.MethodsBetween 2008 and 2013, 87 patients were admitted in our Intensive Care Unit for suspected Takotsubo syndrome, of whom 6 previously experienced acute cerebral symptoms with either IS or EE, within two days. Takotsubo syndrome was diagnosed on Cardiac Magnetic Resonance, e…

medicine.medical_specialtyEjection fractionbiologybusiness.industryCardiomyopathy[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.diseaseTransient apical ventricular dysfunctionCulpritTroponinHemiparesis[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Heart failureT waveInternal medicinemedicinebiology.proteinCardiologyST segmentTakotsubo cardiomyopathymedicine.symptombusinessCardiology and Cardiovascular MedicineComputingMilieux_MISCELLANEOUSArchives of Cardiovascular Diseases Supplements
researchProduct

Effects of Two Different ACE Inhibitors, Captopril and Delapril, in the Early Phases of Acute Anterior Myocardial Infarction

1999

Objective: This study was aimed at investigating the effects of captopril or delapril before and just after thrombolysis in acute anterior myocardial infarction (AMI). Patients and Methods: Study participants consisted of 89 patients, hospitalised within 4 hours of the onset of symptoms. Patients were randomly divided into two groups: the first group (45 patients, pretreatment group) received captopril 6.25mg or delapril 7.5mg orally about 15 minutes before intravenous administration of recombinant tissue plasminogen activator (rt-PA) 100mg; the second group (44 patients, late-treatment group) received captopril or delapril about 4 to 6 hours after thrombolytic treatment. Captopril/delapril…

medicine.medical_specialtyEjection fractionbiologybusiness.industrymedicine.medical_treatmentDelaprilCaptoprilGeneral MedicineThrombolysismedicine.diseaseBlood pressureHeart failureInternal medicinemedicinebiology.proteinCardiologyPharmacology (medical)Creatine kinasecardiovascular diseasesMyocardial infarctionbusinessmedicine.drugClinical Drug Investigation
researchProduct

Role of antiangiogenic VEGF-A165b in angiogenesis and systolic function after reperfused myocardial infarction

2021

Abstract Introduction and objectives Angiogenesis helps to reestablish microcirculation after myocardial infarction (MI). In this study, we aimed to further understand the role of the antiangiogenic isoform vascular endothelial growth factor (VEGF)-A165b after MI and to explore its potential as a coadjuvant therapy to coronary reperfusion. Methods Two mice MI models were formed: a) permanent coronary ligation (nonreperfused MI); b) transient 45-minute coronary occlusion followed by reperfusion (reperfused MI); in both models, animals underwent echocardiography before euthanasia at day 21 after MI induction. We determined serum and myocardial VEGF-A165b levels. In both experimental MI models…

medicine.medical_specialtyEjection fractionbusiness.industryAngiogenesisGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseMicrocirculationBlockadeVascular endothelial growth factor03 medical and health scienceschemistry.chemical_compound0302 clinical medicinechemistryCoronary occlusionHeart failureInternal medicinemedicineCardiologyMyocardial infarctionbusinessRevista Española de Cardiología (English Edition)
researchProduct

Association between silent atrial fibrillation and heart failure after acute myocardial infarction

2013

medicine.medical_specialtyEjection fractionbusiness.industryCardiogenic shock12 lead ecgAtrial fibrillationmedicine.diseaseHeart failureInternal medicineHospital admissionmedicineCardiologyMyocardial infarctionCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Clinical utility of cardiopulmonary exercise testing in patients with heart failure with preserved ejection fraction

2017

medicine.medical_specialtyEjection fractionbusiness.industryCardiopulmonary exercise testingStroke volume030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineInternal medicineHeart failuremedicineCardiologyIn patient030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractionEuropean Journal of Heart Failure
researchProduct

Predictors of self-reported heart failure - results from the Gutenberg Health study

2013

medicine.medical_specialtyEjection fractionbusiness.industryCoronary arteriosclerosismedicine.diseaseNew York Heart Association ClassificationInternal medicineHeart failureArea under curvemedicineCardiologyMedical historyCardiology and Cardiovascular MedicineSelf reportbusinessCohort studyClinical psychologyEuropean Heart Journal
researchProduct

Normalwerte für die Dobutamin-Streßechokardiographie*

2008

UNLABELLED Dobutamine stress echocardiography having established itself as a sensitive method for diagnosing coronary heart disease, even in the absence of normative values, the physiological haemodynamics as well as the physiological values for global and regional left ventricular myocardial function were measured. TEST PERSONS AND METHODS 14 healthy subjects (ten men, four women; median age 25 [range 21-32] years) underwent dobutamine stress echocardiography according to an internationally practised dosage steps protocol (5-40 micrograms/kg/min with additional 0.5 mg atropine at 40 micrograms). RESULTS Maximal infusion rate achieved a serum dobutamine level of 1.67 micrograms/ml with mini…

medicine.medical_specialtyEjection fractionbusiness.industryDiastoleHemodynamicsGeneral MedicineContractilityAtropineBlood pressureInternal medicineHeart ratemedicineCardiologyDobutaminebusinessmedicine.drugDMW - Deutsche Medizinische Wochenschrift
researchProduct

evaluation of BNP plasma levels and bioelectrical impedance analysis (BIA) in decompensated heart failure. A double blind study

2005

medicine.medical_specialtyEjection fractionbusiness.industryFurosemidePlasma levelsmedicine.diseaseDouble blind studyFluid intakeHeart failureInternal medicineHeart rateInternal MedicineCardiologyMedicinebusinessBioelectrical impedance analysismedicine.drug
researchProduct

P776 Stress ecocardiography and speckle tracking analysis in patients with heart failure and preserved ejection fraction

2020

Abstract BACKGROUND Heart failure with preserved ejection fraction (HFpEF) is characterized by heart failure symptoms despite preserved LV systolic function together with at least one among left ventricle hypertrophy/left atrial enlargement plus diastolic dysfunction (DD) and increased brain natriuretic peptide levels. Rest echocardiography could still be normal despite patients experience HF symptoms. Speckle tracking analysis (STE) analyzes myocardial deformation and is able to identify subtle left ventricular dysfunction. PURPOSE to analyze the added value of stress echocardiography to improve diagnostic accuracy in patients with normal ejection fraction and unexplained dyspnoea by evalu…

medicine.medical_specialtyEjection fractionbusiness.industryGeneral Medicinemedicine.diseaseTracking (particle physics)Stress (mechanics)Speckle patternHeart failureInternal medicineCardiologyMedicineRadiology Nuclear Medicine and imagingIn patientCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal - Cardiovascular Imaging
researchProduct

P3543Rehospitalization burden in heart failure with mid-range ejection fraction and morbidity burden. Is it a distinct phenotype?

2019

Abstract Heart failure with mid-range ejection fraction (HFmrEF) has been recognized as a distinct HF phenotype, but wether patients on this category fare worse, similarly, or better than those with HF with reduced EF (HFrEF) or preserved EF (HFpEF) in terms of rehospitalization risk over time remains unclear. We therefore sought to characterize the mordibity burden of HFmrEF patients by evaluating the risk of recurrent hospitalizations following an admission for acute HF. Methods We prospectively included 2,961 consecutive patients discharged for acute HF in our institution from 2004 to 2017. Patients were categorized according to their ejection fraction (EF) obtained by an echocardiograph…

medicine.medical_specialtyEjection fractionbusiness.industryHeart failureInternal medicinemedicineCardiologyCardiology and Cardiovascular Medicinemedicine.diseasebusinessPhenotypeEuropean Heart Journal
researchProduct